Treatment of mucocutaneous manifestations in Behçet’s disease with anakinra: a pilot open-label study
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Grayson, Peter C.
Sen, H. Nida
Sibley, Cailin H.
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (intramural funding, 1K23AR068440-01)
Text and Data Mining valid from 2017-03-24
Version of Record valid from 2017-03-24
17 August 2016
6 January 2017
24 March 2017